To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
FOX 2
A researcher and his team in Spain have identified a combination of drug therapies that is showing promise in preclinical studies for treating pancreatic cancer. Asfar Azmi, Ph.D., scientist, director of the Pancreatic Cancer Research Initiative and member of the Molecular Therapeutics Research Program at Karmanos, joined FOX 2 to talk about this new discovery, what it means for patients, and how he, his team, and other Karmanos colleagues are studying this disease. Dr. Azmi said it may take some time for this treatment to be studied in clinical trials.
Watch the interview here.